Literature DB >> 10092489

Differences in the expression and localization of human melanotransferrin in lepidopteran and dipteran insect cell lines.

D D Hegedus1, T A Pfeifer, D A Theilmann, M L Kennard, R Gabathuler, W A Jefferies, T A Grigliatti.   

Abstract

The ability of several lepidopteran and dipteran insect cell lines to express human melanotransferrin (p97), a glycosyl phosphatidylinositol (GPI)-anchored, iron-binding sialoglycoprotein, was assessed. Spodoptera frugiperda-derived (Sf9) cell lines, transformed with the p97 gene under control of a baculovirus immediate-early promoter, were able to constitutively express the protein and correctly attach it to the outer cell membrane via a GPI anchor as demonstrated by PI-PLC treatment. In contrast, stable constitutive expression could not be demonstrated with cell lines derived from either Drosophila melanogaster (Kc1 or SL2) or Lymantria dispar (Ld652Y) despite the observation that p97 could be detected in transient expression assays. This may indicate that the long-term expression and accumulation of p97 is inhibitory to Drosophila cells, possibly due to improper localization of the protein and resultant competition for cellular iron. In stably transformed Sf9 cells, p97 was expressed on the cell at a maximal level of 0.18 microg/10(6) cells and was secreted at a maximal rate of 9.03 ng/10(6) cells/h. This level was comparable to the amount expressed with the baculovirus system (0.37 microg/10(6) cells and 31.2 ng/10(6) cells/h) and transformed CHO cells (0.88 microg/10(6) cells and 7.8 ng/10(6) cells/h). Deletion of the GPI cleavage/attachment site resulted in an eightfold increase in the secretion rate of p97, when compared to the intact construct suggesting that the rate-limiting step involves processing of the GPI anchor. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10092489     DOI: 10.1006/prep.1998.1021

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  7 in total

1.  Production of a self-activating CBM-factor X fusion protein in a stable transformed Sf9 insect cell line using high cell density perfusion culture.

Authors:  Volker M Gorenflo; Tom A Pfeifer; Gary Lesnicki; Emily M Kwan; Thomas A Grigliatti; Douglas G Kilburn; James M Piret
Journal:  Cytotechnology       Date:  2004-03       Impact factor: 2.058

2.  A peptide derived from melanotransferrin delivers a protein-based interleukin 1 receptor antagonist across the BBB and ameliorates neuropathic pain in a preclinical model.

Authors:  George Thom; Mei-Mei Tian; Jon P Hatcher; Natalia Rodrigo; Matthew Burrell; Ian Gurrell; Timothy Z Vitalis; Thomas Abraham; Wilfred A Jefferies; Carl I Webster; Reinhard Gabathuler
Journal:  J Cereb Blood Flow Metab       Date:  2018-05-30       Impact factor: 6.200

Review 3.  Glycoproteins from insect cells: sialylated or not?

Authors:  I Marchal; D L Jarvis; R Cacan; A Verbert
Journal:  Biol Chem       Date:  2001-02       Impact factor: 3.915

4.  Functional analysis of the transmembrane (TM) domain of the Autographa californica multicapsid nucleopolyhedrovirus GP64 protein: substitution of heterologous TM domains.

Authors:  Zhaofei Li; Gary W Blissard
Journal:  J Virol       Date:  2008-01-23       Impact factor: 5.103

5.  An incremental approach to automated protein localisation.

Authors:  Marko Tscherepanow; Nickels Jensen; Franz Kummert
Journal:  BMC Bioinformatics       Date:  2008-10-20       Impact factor: 3.169

6.  Discovery of a Highly Conserved Peptide in the Iron Transporter Melanotransferrin that Traverses an Intact Blood Brain Barrier and Localizes in Neural Cells.

Authors:  Chaahat S B Singh; Brett A Eyford; Thomas Abraham; Lonna Munro; Kyung Bok Choi; Mark Okon; Timothy Z Vitalis; Reinhard Gabathuler; Chieh-Ju Lu; Cheryl G Pfeifer; Mei Mei Tian; Wilfred A Jefferies
Journal:  Front Neurosci       Date:  2021-06-02       Impact factor: 4.677

7.  Assessment of selective toxicity of insect cell expressed recombinant A1-GMCSF protein toward GMCSF receptor bearing tumor cells.

Authors:  A Jahanian-Najafabadi; S Bouzari; M Oloomi; M Habibi Roudkenar; M A Shokrgozar
Journal:  Res Pharm Sci       Date:  2012-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.